Property:Age groups specification
This is a property of type Text.
K
Kessels et al. (2017): Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma A Randomized Clinical Trial +
NI +
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial +
Intervention arm: median and interquartile ranges of age at diagnosis: 60.5 (55-71)
Placebo arm: median and interquartile ranges of age at diagnosis: 62 (54-69) +
Khodabakhshi et al. (2019): Feasibility, Safety, and Beneficial Effects of MCT-Based Ketogenic Diet for Breast Cancer Treatment: A Randomized Controlled Trial Study +
Age in years, mean (SD) per arm:
intervention arm: 44.8 (8.4)
comparison arm 45.2 (15.0) +
Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial +
Mean value (range):
Intervention arm: 60 years (32-74 years),
Placebo arm: 58 years (39-83 years) +
Konmun et al. (2017): A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy +
Overall median (range) in years: 53 (19-81); per arm:
- intervention arm: 52 (19-81)
- placebo arm: 55 (37-79) +
Kottschade et al. (2011): The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase 3 clinical trial +
≤ 50 years: 39%, > 50 years: 61% +
Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients +
Mean (SD): 68 (9.6) years +
Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial +
Mean (SD): 64.4 (1.7) years +
L
Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer +
Age in years, mean (min-max) per arm:
Selenium arm: 52.14 (22-81), placebo arm: 54.74 (18-81) +
Li et al. (2018): Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial +
Age in years, mean (SD) per group:
ginger-group: 57.52 (7.24), placebo-group: 57.46 (7.82) +
Lian et al. (2014): Comparing the Effectiveness of Green Tea versus Topical Metronidazole Powder in Malodorous Control of Fungating Malignant Wounds in a Controlled Randomised Study +
Median Age (min-max) per arm:
Green tea arm: 55 (33-81) years, Metronidazole arm: 46 (35-81) years +
Lichtmann et al. (2018): Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain +
Mean (SD) age per arm:
Intervention arm = 59.2 (12) years
Placebo arm = 60.7 (11.1) years +
Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study +
Intervention arm: MW (SD): 50 (11)
Placebo arm: MW (SD): 51 (11) +
Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study +
Intervention arm: mean (SD): 50 (11)
Placebo arm: mean (SD): 51 (11) +
Lin et al. (2009): Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis +
Intervention arm: mean (SD): 49.53 (13.75)
Placebo arm: mean (SD): 50.88 (10.01) +
Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study +
Nasopharyngeal cancer: intervention arm: mean (SD): 50.60 (14.17)
Nasopharyngeal cancer: placebo arm: mean (SD): 52.63 (11.28)
Oral cancer: intervention arm: mean (SD): 50.48 (9.10)
Oral cancer: placebo arm: mean (SD): 51.30 (10.81) +
Lissoni et al. (1998): Biotherapy with the Pineal Immunomodulating Hormone Melatonin versus Melatonin plus Aloe vera in Untreatable Advanced Solid Neoplasms +
Mean age (range) per arm:
Aloe arm: 63 (48-80) years
Placebo arm: 61 (46-79) years +
Lissoni et al. (2009): A Randomized Study of Chemotherapy versus Biochemotherapy with Chemotherapy plus Aloe arborescens in Patients with Metastatic Cancer +
Median age (range) per arm:
Aloe arm: 64 (61-77) years
Control arm: 65 (58-79) years +
Liu et al. (2010): Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial +
Mean (SD)
Arm A: 44 (14)
Arm B: 42 (14)
Arm C: 43 (13)
Arm D: 39 (12) +